Dr. Barbara Lohmann
Specialist vet for Pharmacology and Toxicology, European Registered Toxicologist (ERT)
Dr. Barbara Lohmann is co-founder of CFCS-Consult (2007) and has been manager and leading expert of the human health / toxicology section till early 2019. She is veterinary specialist for pharmacology and toxicology since 1999 and a “European Registered Toxicologist” (ERT) with more than 20 years of research and consulting experience in the fields of pathology, pharmacology, toxicology and human safety assessment of chemicals. She earned her Ph.D. from the Helmholtz Zentrum Munich: German Research Center for Environmental Health in 1992.
Stefanie Göller-Lucas
Stefanie Göller-Lucas is Chemical Engineer with main focus on Biochemistry and Biotechnology. After first experiences in a laboratory for genetic toxicity, she worked for the pharmaceutical industry in the field of clinical research for several years as project leader. She joined the CFCS team in 2008 and is working as collaborating consultant.
Since the first REACH registration phase she is already conducting registration dossiers, including the preparation of IUCLID-datasets and chemical safety reports. Furthermore, Stefanie supports the CFCS team especially within toxicological issues and other upcoming questions during the registration of chemicals under the REACH regulation.–
Dr. Roland Stangl
Dr. Roland Stangl joined CFCS as a collaborating consultant in 2019. He studied chemistry at the Julius-Maximilian-University Würzburg where he also obtained his doctorate in organic chemistry in 1984. Subsequently he worked in companies in the chemical industry. After positions in the development of adhesives he took on responsibilities in the regulatory field: generation of safety data sheets, classification and labelling of chemicals, notification and registration of chemicals in various areas of application. In this function he also was a member in bodies of national and international chemical associations. Since 2007 he works on the registration and evaluation of substances under the REACH legislation. This includes, in particular, the conception and preparation of registration dossiers, activities in REACH consortia and the communication with the European Chemicals Agency on the conduction of substance and dossiers evaluation.
_
_